Oncodesign's
corporate fact sheet
 Download
Latest News
Oncodesign® announced an
exciting technology license...
June 16, 2010
More
Pharmimage® adds members
and plans extensions...
June 1,
2010
More
|
|
Pharmacological expertise
for anticancer therapies from target to patient : a unique oncology
preclinical CRO |
-
 More than 1000 studies conducted with new compounds
and reference drugs, 230 clients worldwide
- Proof of concept in human tumor xenograft models,
> 300 tumor cell lines available
- Emphasis on pharmacokinetic/pharmacodynamic
relationship
- Translational research using pharmaco-imaging (MRI,
PET) for biomarker validation
|
|
Home
